IDbyDNA Raises $9M in Series A for Infectious Disease Diagnostics
IDbyDNA announces today that it has closed $9 million in Series A financing to develop its Taxonomer-based infectious disease diagnostic technologies.
IDbyDNA announces today that it has closed $9 million in Series A financing to develop its Taxonomer-based infectious disease diagnostic technologies.
In this Scope Radio Interview, Dr. Lynn Jorde and Dr. Eric Green discuss opportunities and challenges in Genomic Medicine.
PHEVOR software from Mark Yandell’s USTAR Lab, identifies undiagnosed illnesses.
See how UCGD and Omicia are striving to make genome analysis a common practice for revealing potential disorders.
Stephen Guthery, M.D discusses how genomic sequencing can affect treatment plans for rare diseases.